Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Selenoprotein P is a secreted, selenium-rich plasma glycoprotein encoded by the SELENOP gene and characterized by the presence of ten selenocysteine residues—one in the N-terminal domain (redox motif, antioxidant activity) and nine in the C-terminal region (selenium transport/storage)[1][3][4][5][6][7][9]. It serves essential functions as the principal transporter of selenium to various tissues, notably brain, testis, and kidney, maintaining selenium homeostasis and protecting cells from oxidative stress. Selenoprotein P also binds multiple metal ions, possibly conferring resistance to heavy metal toxicity. Its plasma levels are clinically used as a biomarker for nutritional selenium status. Genetically, loss of function or deficiency of SeP leads to neurological, reproductive, and immune disorders in mice, underlining its critical physiological role[5][7]. SeP interacts with specific receptors (ApoER2, megalin) to mediate tissue uptake of selenium. There are currently no approved drugs directly targeting SeP; current therapeutics involve selenium donor compounds for deficiency states[4]. Monitoring and manipulating selenium levels must be conducted with care due to tight systemic regulation and potential toxicity.
Selenium donor or supplement: increasing substrate availability for SeP, targeting selenium deficiency; Metal ion chelation/competition: sequestration or binding of toxic metals; modulating oxidative stress via metal-binding
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selenoprotein P (SeP).